Researchers have raised concerns about the effectiveness of current National Health Service guidelines for identifying younger women at elevated risk of breast cancer. The screening criteria established by the National Institute of Health and Care Excellence focus exclusively on inherited genetic factors and family history, excluding consideration of other important variables such as lifestyle, reproductive history, and hormone use.
According to findings published in the British Journal of Cancer, a comprehensive risk assessment tool identified eight times as many women in the under-50 age group who developed breast cancer compared to those identified through existing Nice guidelines. The researchers note that approximately one in seven women develops breast cancer during their lifetime, yet only 5-10% of cases involve inherited genes. The study highlights that three-quarters of women under 50 who develop breast cancer within a decade have no family history of the disease, which is the primary criterion in current Nice guidelines.
The research team from Cambridge University and the Institute of Cancer Research employed a risk calculator called Boadicea that incorporates family history, lifestyle factors, reproductive history, and genetic information to generate a risk score. If applied broadly to all women under 50, the tool would identify approximately 26.5% as having above-average risk warranting further assessment. This contrasts sharply with current Nice criteria, which would refer only 1.4% of women in this age group for additional evaluation.
While lead researcher Dr Juliet Usher-Smith called for the NHS to review its criteria in light of these findings, she acknowledged that expanded screening could increase workload demands and potentially cause unnecessary anxiety for some women. Nice stated it welcomed the research and recognized the potential of multifactorial risk assessment tools but indicated that existing evidence did not support changing current guidelines at this time. The UK National Screening Committee regularly evaluates the NHS breast screening programme across all four nations, which currently invites women for screening beginning at age 50.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI